Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02323906 |
| Title | Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Celgene Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94115 | United States | Details | |
| University of Florida College of Med | Gainesville | Florida | 32610-0277 | United States | Details | |
| Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Indiana University Cancer Center | Indianapolis | Indiana | 46202-528 | United States | Details | |
| Henry Ford Hospital | Detroit | Michigan | 48202 | United States | Details | |
| Greenville Hospital System | Greenville | South Carolina | 29605 | United States | Details | |
| University of Utah Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details | |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |